Evidence map›Paper›PMID 19751240›Full record

ArticleBritish journal of haematology2009

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.

Wei Ding, Grzegorz S Nowakowski, Traci R Knox, Justin C Boysen, Mary L Maas, Susan M Schwager, Wenting Wu, Linda E Wellik, Allan B Dietz, Asish K Ghosh and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of haematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Wei DingDivision of Hematology/Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Grzegorz S Nowakowski
Traci R Knox
Justin C Boysen
Mary L Maas
Susan M Schwager
Wenting Wu
Linda E Wellik
Allan B Dietz
Asish K Ghosh
Charla R Secreto
Kay L Medina
Tait D Shanafelt
Clive S Zent
Timothy G Call
Neil E Kay
Palmetto Hematology Oncology · USWinnMed · US

Funding

VEGF Function in B-CLLR01CA116237 · NCI · MAYO CLINIC ROCHESTER · PI KAY, NEIL E · 2006 to 2010
$1.3M
NCI NIH HHS CA-1116237NCI NIH HHS R01 CA116237
6 · The paper itself

Abstract

It was hypothesized that contact between chronic lymphocytic leukaemia (CLL) B-cells and marrow stromal cells impact both cell types. To test this hypothesis, we utilized a long-term primary culture system from bone biopsies that reliably generates a mesenchymal stem cell (MSC). Co-culture of MSC with CLL B-cells protected the latter from both spontaneous apoptosis and drug-induced apoptosis. The CD38 expression in previously CD38 positive CLL B-cells was up-regulated with MSC co-culture. Upregulation of CD71, CD25, CD69 and CD70 in CLL B-cells was found in the co-culture. CD71 upregulation was more significantly associated with high-risk CLL, implicating CD71 regulation in the microenvironment predicting disease progression. In MSC, rapid ERK and AKT phosphorylation (within 30 min) were detected when CLL B-cells and MSC were separated by transwell; indicating that activation of MSC was mediated by soluble factors. These findings support a bi-directional activation between bone marrow stromal cells and CLL B-cells.

Indexed as

AgedAged, 80 and overAntigens, CDApoptosisB-LymphocytesCell CommunicationCell DifferentiationCoculture TechniquesDisease ProgressionEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFemaleHumansImmunophenotypingLeukemia, Lymphocytic, Chronic, B-CellLymphocyte ActivationAntigens, CDCD71 antigenExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins c-aktReceptors, Transferrin

Identifiers

PMID19751240
PMCPMC2783570
OpenAlexW2018531061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.